- Home
- LSTR vs ZLAB Comparison
LSTR vs ZLAB Comparison
Compare LSTR & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTR
- ZLAB
- Stock Information
- Founded
- LSTR 1991
- ZLAB 2013
- Country
- LSTR United States
- ZLAB China
- Employees
- LSTR N/A
- ZLAB N/A
- Industry
- LSTR Trucking Freight/Courier Services
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- LSTR Industrials
- ZLAB Health Care
- Exchange
- LSTR Nasdaq
- ZLAB Nasdaq
- Market Cap
- LSTR 5.0B
- ZLAB 4.3B
- IPO Year
- LSTR 1993
- ZLAB 2017
- Fundamental
- Price
- LSTR $128.37
- ZLAB $36.82
- Analyst Decision
- LSTR Hold
- ZLAB Buy
- Analyst Count
- LSTR 14
- ZLAB 5
- Target Price
- LSTR $148.42
- ZLAB $54.28
- AVG Volume (30 Days)
- LSTR 450.5K
- ZLAB 830.0K
- Earning Date
- LSTR 07-29-2025
- ZLAB 08-07-2025
- Dividend Yield
- LSTR 2.80%
- ZLAB N/A
- EPS Growth
- LSTR N/A
- ZLAB N/A
- EPS
- LSTR 4.77
- ZLAB N/A
- Revenue
- LSTR $4,802,153,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- LSTR $2.21
- ZLAB $44.07
- Revenue Next Year
- LSTR $8.26
- ZLAB $49.13
- P/E Ratio
- LSTR $26.93
- ZLAB N/A
- Revenue Growth
- LSTR N/A
- ZLAB 43.72
- 52 Week Low
- LSTR $128.44
- ZLAB $16.01
- 52 Week High
- LSTR $196.86
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- LSTR 32.02
- ZLAB 50.98
- Support Level
- LSTR $130.42
- ZLAB $36.51
- Resistance Level
- LSTR $144.51
- ZLAB $41.20
- Average True Range (ATR)
- LSTR 4.07
- ZLAB 1.21
- MACD
- LSTR -0.98
- ZLAB 0.18
- Stochastic Oscillator
- LSTR 1.65
- ZLAB 42.75
About LSTR Landstar System Inc.
Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage. Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.